The meta-analysis found a significant reduction in anxiety and depression scores in patients receiving real NIBS compared to those in the control group, indicating that NIBS can alleviate clinical symptoms in patients with anxiety disorders.
Significant reductions in anxiety scores compared to placebo were observed at multiple time points, with improvements in anxiety and depression symptoms correlating at subacute and sustained time points.
Stronger pre-treatment functional connectivity in specific brain regions was associated with greater clinical improvement in patients undergoing CBT.
The study found that task-based brain signal variability was a strong predictor of treatment outcomes, with a total predictive accuracy of .77, indicating significant improvement in social anxiety symptoms post-treatment.
The intervention is designed to be acceptable to autistic children and their families, promoting adaptive learning and emotional regulation while celebrating autistic differences.
Significant reductions in anxiety, depression, and PTSD symptoms were observed, with effect sizes ranging from 0.75 to 0.86 at 3 months and sustained effects at 6 months. A substantial percentage of participants reported clinically meaningful improvements.
Participants experienced medium to large reductions in both state and trait anxiety, which persisted for at least one week post-ceremony. Increases in mindfulness and decreases in neuroticism were also observed, correlating with reductions in anxiety.
Participants in the TMR group showed reduced subjective anxiety during the anticipatory phases of exposure therapy. Additionally, increased REM sleep duration and more TMR stimulations correlated with lower anxiety levels (higher RMSSD) in the TMR group.
The treatment showed significant symptom reduction in both trials, with greater improvements in the active treatment group compared to the control group. High acceptability of the app was reported by participants.
Participants in the experimental group are expected to show significant improvements in emotion dysregulation symptoms, ER skills, anxiety and depressive symptoms, and cognitive functions such as working memory and cognitive flexibility, compared to the control group.
Adolescents using Togetherall showed significant engagement, with 47.9% accessing more than one course and 27% utilizing self-help resources. Greater engagement with the platform was associated with reduced anxiety symptoms, indicating positive treatment outcomes for users.
Identified distinct trajectories of symptom improvement and nonresponse, with factors such as better overall health and younger age linked to higher remission rates.
The study found that models based on resting-state functional connectivity and structural MRI could predict treatment outcomes, with a mean absolute error of approximately 3.5 points, indicating some level of predictive validity despite the small sample size.
The review found that psychological interventions were effective in reducing symptoms of perinatal anxiety, with a medium post-treatment effect size. They also demonstrated efficacy in addressing comorbid anxiety and depression, with positive outcomes across various treatment modalities.
Participants reported increased awareness of their smoking patterns, development of personalized strategies for quitting, and the importance of supportive practitioner interactions. Regular sessions and timely access to the intervention were also highlighted as beneficial.
The treatments showed potential for rapid and prolonged reduction in depressive and anxiety symptoms, with specific benefits noted for different populations, such as those with treatment-resistant conditions or life-threatening illnesses.
Early identification and intervention can significantly improve prognosis and reduce the incidence of mood and anxiety disorders in adolescents.
The study suggests that addressing sociodemographic and environmental factors can enhance early detection and treatment of SM, potentially improving children's social functioning and educational outcomes.
The review found that physical activity was negatively associated with depression in 61.2% of studies, anxiety in 57.1%, and positively associated with wellbeing in 64.1%.
Individuals with affective disorders exhibited greater information-seeking (directed exploration) in resting conditions, but this was reduced by the anxiety induction. The study highlights the complex relationship between trait and state anxiety.
The findings indicate that higher CRP concentration is associated with lower risks of depressive and anxiety symptoms, while higher IL-6 activity is linked to increased risk for depressive symptoms. The associations were stronger for depression than for anxiety, particularly in women.
In vivo exposure resulted in significantly higher heart rate variability (HRV) levels, indicating a stronger activation of the parasympathetic nervous system compared to VR exposure, suggesting better therapeutic outcomes with in vivo methods.
Increased likelihood of medication prescription for children with anxiety, depression, and both conditions, particularly in older children and those with comorbidities.
The interventions led to a significant reduction in anxiety (d= -0.35) and depression (d= -0.37). Spiritual care education significantly reduced postpartum stress disorder (d= -62.00).
The study found that individuals with the GG genotype of the TPH2 gene experienced increased subjective anxiety and reduced vmPFC reactivity to threat-related stimuli following ATD, indicating a genetic vulnerability to anxiety.
Citalopram was found to reduce the neural interoceptive response to visceral sensations, particularly in the context of anxiety. This suggests a potential therapeutic effect in modulating the relationship between interoception and anxiety, leading to a better understanding of how SSRIs can influence anxious states.